Randox has been at the forefront of the clinical IVD market for over 35 years, developing and manufacturing some of the most renowned and high quality tests for hospitals all over the world. Making Randox a global leader in human diagnostics.
Over 15 years ago and with an R&D investment of in excess of £250million, Randox developed the world’s first and only multiplex testing platform – Biochip Array Technology.
What does this mean for us today?
Using this patented technology and the Evidence Series of analysers, also designed and built by Randox, Randox Health private laboratories are able to detect and analyse 100s of biomarkers from a single sample. The Biochip has changed the landscape of testing forever, truly revolutionary.